Showing results (391-400 of 1,065) with videos related to
Sort By:
Pageof 107
Anti-Cancer Drug Design|June 1, 1995
Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugsG R Pettit, C Temple, V L Narayanan, et al.Journal of Gastroenterology and Hepatology|November 1, 1990
Primary biliary cirrhosis: clinicopathological characteristics and outcomeG P Jeffrey, W D Reed, K B ShilkinJournal of Chemical Theory and Computation|December 5, 2015
Revised Basis Sets for the LANL Effective Core PotentialsLindsay E Roy, P Jeffrey Hay, Richard L MartinBehavioural Brain Research|March 1, 2021
Targeting muscarinic receptors to treat schizophreniaDaniel J Foster, Zoey K Bryant, P Jeffrey ConnCurrent Topics in Medicinal Chemistry|September 24, 2005
New therapeutic frontiers for metabotropic glutamate receptorsColleen M Niswender, Carrie K Jones, P Jeffrey ConnDiscovery Medicine|December 4, 2012
Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signalingMeredith J Noetzel, Carrie K Jones, P Jeffrey ConnInorganic Chemistry|September 25, 2008
Theoretical studies on the redox potentials of Fe dinuclear complexes as models for hydrogenaseLindsay E Roy, Enrique R Batista, P Jeffrey HayTrends in Pharmacological Sciences|December 9, 2008
Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophreniaP Jeffrey Conn, Craig W Lindsley, Carrie K JonesNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 10, 2009
The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipientsNeil Boudville, Muna Salama, Gary P Jeffrey, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 30, 2015
Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent CationsBrian Dean, Shaun Hopper, P Jeffrey Conn, et al.Pageof 107